Michael Mason, VP, Finance and Treasurer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 3,750 shares at $79.74 ($295K) on 2014-02-03, disclosed to the SEC on 2014-02-04.
Scheduled sale ($295k) by VP, Finance and Treasurer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.08 | 1,540 | $120K | 40.8% |
| 2 | $79.04 | 2,110 | $167K | 56.5% |
| 3 | $79.74 | 100 | $8K | 2.7% |
| Total | $78.66 avg | 3,750 | $295K | 100% |
| Filing → |
| KPTI | SELL | 2024-03-04 | $40K | — | Filing → |
| KPTI | SELL | 2024-02-29 | $3K | — | Filing → |
| KPTI | SELL | 2024-02-08 | $7K | — | Filing → |